FDA Extends Priority Review period of Cladribine Tablets by Three Months GENEVA, Switzerland, November 26, 2010 - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
More than 40 manufacturers and automotive suppliers to showcase vehicles and innovation in Detroit
LONDON, November 26, 2010 - TraderMade, worldwide provider of market leading real-time charting and technical analysis solutions are pleased to announce that Alan Clarke has joined the company in a non-exec capacity to work with the Business Development team. This is the latest part of the company restructure which has brought focus to TMI worldwide sales activities. Alan's role will include strategic alliances as well as business and product development.